Dark Light

RoC Derm Correxion Dual Eye Cream with Advanced Retinol + Peptides for Puffy Eyes and Dark Circles, 0.68 Ounces


$29.97

Compare

Price: $29.97
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on [relevant Amazon Site(s), as applicable] at the time of purchase will apply to the purchase of this product.”


NON-INVASIVE EYE LIFT: A 2-in-1 eye duo developed with dermatologists and plastic surgeons to help treat the upper and lower eye areas. The upper eye gel dramatically lifts and firms the look of eyelids, while the lower eye cream visibly smooths, depuffs, and reduces dark circles. Together these formulas with unique Retinol and Peptide combinations deliver clinically proven results for all areas of the eye. *Source: Ophthalmologist-controlled clinical study, Essex Testing Clinic, July 2023.
Package Dimensions ‏ : ‎ 3.68 x 2.76 x 2.68 inches; 2.72 ounces
Item model number ‏ : ‎ 240137500
UPC ‏ : ‎ 840103213750
Manufacturer ‏ : ‎ RoC
ASIN ‏ : ‎ B0CDNHBSV1
Country of Origin ‏ : ‎ USA

PPROVEN RESULTS: Together these two formulas with unique Retinol and Peptide combinations deliver clinically proven results for all areas of the eye. 90 percent experienced visibly lifted eyelids and 96 percent saw visibly reduced lines and dark circles in two weeks
ANTI-AGING FORMULAS: Whether you’re looking for a solution for deep wrinkles, fine lines, dark circles, crow’s feet, uneven skin tone or dry skin, we have an anti-aging formula that’s right for you.
SCIENCE and BEAUTY: We produce a wide array of skin care products and treatments including moisturizers, cleansers, serums, skin tone and wrinkle regimens and creams for eyes, neck, decollete and much more.
SKIN CARE INNOVATION: Our products are recognized by beauty industry leaders and dermatologists for their best-in-class effectiveness. We continue to research and innovate new formulas for healthier skin.
Source: Ophthalmologist-controlled clinical study, July 2023.